AstraZeneca turns to Samsung Biologics to help fuel Asia drugs push
Bio Pharma Dive
SEPTEMBER 24, 2020
The British drugmaker struck a manufacturing deal with Samsung to expand its ability to supply drugs to the Asia Pacific region, an area that's been key to its recent growth.
Let's personalize your content